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Aims Alcohol septal ablation (ASA) has been successful in the treatment of symptomatic hypertrophic
obstructive cardiomyopathy (HOCM). The aim of this study is to evaluate the effects of ethanol-induced
myocardial infarcts on regional myocardial function using cardiac magnetic resonance (CMR) tissue
tagging and 3-dimensional (3D) strain analysis.
Methods and results In nine patients (age 52+ 15 years) who underwent ASA, CMR was performed prior
to and 6 months after the procedure. Regional myocardial mass was evaluated using cine imaging.
Myocardial tagging was used to calculate systolic 3D myocardial strain values. These strain values
were used to calculate the shortening index (SI), a robust parameter for myocardial contraction.
Maximum end-systolic (ES) SI and systolic SI rate were quantiﬁed in three circumferential segments:
septum, adjacent, and remote (lateral) myocardium. Compared with baseline, septal and non-septal
mass decreased at follow-up (from 72+ 27 to 59+ 21 g; P ¼ 0.008 and from 131+ 34 to 109+ 30 g;
P ¼ 0.008, respectively). In the septum, maximum ES SI and SI rate remained unchanged after ASA.
In adjacent myocardium, ES SI remained unchanged, whereas SI rate improved (from 256.5+ 21.1
to 270.0+ 16.7%/s; P ¼ 0.02). Both ES SI and SI rate improved signiﬁcantly in remote myocardium
(from 216.9+ 2.8 to 218.8+ 3.2%; P ¼ 0.02 and from 270.3+ 9.2 to 286.1+ 15.0%/s; P ¼ 0.01,
respectively).
Conclusion Reduction of left ventricular (LV) outﬂow tract obstruction in symptomatic HOCM is associ-
ated with a signiﬁcant reduction in myocardial mass and improvement of intramural systolic function in
the lateral (remote) wall, indicating reversed LV remodelling.
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Introduction
Recently, alcohol septal ablation (ASA) has been successfully
introduced to treat symptomatic patients with hypertrophic
obstructive cardiomyopathy (HOCM).1–5 Ablation by ethanol
infusion into septal branches of the left anterior descending
coronary artery results in an artiﬁcially induced septal
myocardial infarction with regional myocardial wall thin-
ning, a decrease of the pressure gradient and left
ventricular (LV) wall stress, and subsequently a relief of
symptoms.6–9
Using cardiac magnetic resonance (CMR) imaging, we have
demonstrated that both septal and non-septal (remote) myo-
cardial mass reduction can be found as early as 1 month after
ASA in patients with HOCM, and mass reduction continues
afterwards.10,11 The reduction in remote LV mass supports
the theory that myocardial hypertrophy in HOCM is not exclu-
sively caused by the genetic disorder, but is also afterload-
dependent and reversible. Few studies report on the
effects of afterload reduction on regional myocardial
function in these patients. The reduction of the Tei index,
an echocardiographic Doppler parameter reﬂecting both
systolic and diastolic LV functions, was found, suggesting
improved myocardial performance.12 Echocardiographic
strain rate imaging has shown reduced systolic function in
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the peri-infarct septal zone and preserved systolic function in
the remote non-ischaemic septal zone directly after ASA.13
CMR tissue tagging with three-dimensional (3D)-strain
analysis is an established method for quantiﬁcation of
regional myocardial function.14–16 When the technique is
used in patients with myocardial infarction because of
coronary artery disease, differences in function between
infarcted and non-infarcted (remote) regions can be
detected accurately. These regional differences in function
are thought to play a role in post-infarct remodelling.17,18
However, it is unknown to what extent a therapeutic and
artiﬁcially induced infarction affects regional function in
patients with obstructive cardiomyopathy with an associ-
ated pre-existent abnormal structure of the myocardium.
On the one hand, the ethanol-induced infarction may
cause a further decline in regional myocardial function
and trigger an adverse remodelling process. On the other
hand, beneﬁcial effects due to the reduction of the pressure
gradient might counterbalance deleterious effects from ASA.
The purpose of this study is to determine the effect of ASA
on regional myocardial function. Three-dimensional myocar-
dial strain was quantiﬁed in nine patients with symptomatic
HOCM before and 6 months after successful ASA.
Methods
Patients
The study protocol was approved by the Committee on Research
Involving Human Subjects and by the Medical Ethics Committee of
the VU University Medical Center, Amsterdam, The Netherlands.
Consecutive patients with HOCM scheduled for ASA and eligible
for CMR imaging were studied. Exclusion criteria were any absolute
or relative contraindication to MR imaging (e.g. pacemaker and
claustrophobia), atrial ﬁbrillation (AF), or failure to give informed
consent. The indication for ASA was based on a signiﬁcant LV
outﬂow tract (LVOT) pressure gradient as documented by echocar-
diography and symptoms [New York Heart Association (NYHA)
functional classes II–IV], despite medical treatment. The septal
ablation procedure has been described previously.10
One patient was excluded for enrolment because of AF. In total, 19
consecutive patients underwent 3D CMR myocardial tagging in
addition to a standard CMR imaging protocol that included volume
and mass measurements and delayed contrast-enhanced (DCE)
imaging. Four patients were lost to 6 months follow-up: three
required pacemaker implantation because of the development of
complete atrioventricular block (in one patient, 3 months after the
procedure) and one declined to return for the follow-up examination.
Two patients with recurrent symptoms were excluded from the ﬁnal
analysis because no successful gradient reduction (.50%) was
achieved after the septal ablation procedure. One of these patients
underwent a redo procedure, and the other underwent a surgical
myectomy in combination with mitral leaﬂet extension because the
patient had an enlarged anterior mitral valve leaﬂet with residual
systolic anterior motion and severe mitral regurgitation. In four
patients, strain analysis was not possible because of poor image
quality: in one patient, breath-holding was inadequate, one patient
developed claustrophobia during the follow-up CMR, one patient
had motion artefacts on FU CMR, and in one patient, tag lines
faded very quickly. Results of the standard CMR protocol in a larger
group (29 patients) have been published elsewhere.11 This article
reports the results of the subgroup that underwent CMR tagging.
Echocardiography
The LVOT pressure gradient was documented by Doppler echocardio-
graphy. In symptomatic patients, a pressure gradient of 50 mmHg
at rest was considered to be signiﬁcant. One patient with a resting
gradient of ,50 mmHg was symptomatic. In this patient, provoca-
tion was applied using the Valsalva manoeuvre, resulting in a
pressure gradient of 50 mmHg.
CMR image acquisition
CMR was performed prior to and 6 months after ASA on a 1.5 T clini-
cal scanner (Sonata, Siemens, Erlangen, Germany), using a four-
element phased-array receiver coil. All images were acquired with
ECG gating and during repeated single breath-holds of 10–15 s
depending on heart rate.
Cine images were acquired using a segmented steady-state free
precession gradient-echo sequence in three long-axis views (2-,
3-, and 4-chamber view) and in multiple short-axis views every
10 mm, covering the entire LV from base to apex.
DCE images were acquired 15–20 min after intravenous adminis-
tration of 0.2 mmol/kg gadolinium-diethylene-triamine pentaacetic
acid (DTPA) in the same views used in cine CMR, using a two-
dimensional segmented inversion-recovery prepared gradient-echo
sequence.19 The DCE images were acquired in ﬁve patients at base-
line and in all patients at follow-up CMR and were used to make sure
that the ablation procedure was successful and that the infarct
region was limited to the septum.10
CMR tissue tagging using spatial modulation of magnetization15,16
was applied to create markers (tags) non-invasively within the myo-
cardium for the calculation of myocardial strain. Five to six parallel
LV short-axis- and three long-axis-tagged images were acquired by a
spoiled gradient echo sequence. A temporal resolution of 30 ms was
achieved by application of a view-sharing technique.
CMR image analysis
Analysis of cine images (global ventricular function)
Global LV function parameters, including end-diastolic volume
(EDV), end-systolic volume (ESV), ejection fraction (EF), and total
and septal myocardial mass, were quantiﬁed using the MASS soft-
ware package (MEDIS, Leiden, The Netherlands). Endocardial and
epicardial borders were traced manually in end-diastolic and ES
frames of all short-axis slices. Papillary muscles were included in
the assessment of LV mass. The septum was deﬁned as the myocar-
dium between the anterior and the posterior junctions of the right
ventricle (RV) to the LV.
Analysis of tagged images (regional myocardial function)
The short-axis- and long-axis-tagged images were processed using a
dedicated software package (SPAMMVU, University of Pennsylvania,
PA, USA).20 After combining the short-axis and long-axis myocardial
motions, tetrahedrons (of myocardium) were created and the 3D
strain values of these tetrahedrons were calculated.21 The normal
strains were expressed in a cardiac coordinate system deﬁned by
the radial, circumferential, and longitudinal directions. The strain
components were computed with respect to these three directions.
The radial strain is deﬁned as the relative change in the length of
a radial line segment and expressed in per cent value. Positive radial
strains represent the local contribution to wall thickening. Negative
values for radial strain imply local wall thinning. Circumferential
and longitudinal strains were deﬁned similar to the radial strain,
quantifying the change in length in the circumferential and
longitudinal directions, respectively. Negative circumferential and
longitudinal strains represent local shortening. From each strain
parameter, peak values were determined and expressed as
‘maximum systolic strain’.
Systolic strain rate was deﬁned as the slope of the strain curve
averaged from ﬁve time frames (from 90 to 210 ms after the QRS
interval), reﬂecting myocardial deformation over time.
The circumferential–longitudinal shear strain gives the change in
the angle between the circumferential and longitudinal line
segments. This circumferential–longitudinal shear angle can be
interpreted as the local contribution to global LV torsion.
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The shortening index (SI) reﬂects the geometric mean of
fractional one-dimensional shortening within the circumferential–
longitudinal plane. The SI is negative for muscle shortening and
directionally insensitive within the plane. SI turns out to be a
robust parameter to quantify myocardial contraction.22
Strain values were averaged from base to apex, and strain par-
ameters were calculated in six circumferential segments; anterior,
antero-lateral, postero-lateral, inferior, infero-septal, and antero-
septal. The infero- and antero-septal segments were considered to
be target areas for the ethanol-induced myocardial infarction.
The anterior and inferior segments were considered as ‘adjacent’
myocardium and the antero- and postero-lateral segments as
‘remote’ area.
Statistical analysis
Results are expressed as mean+ SD. Non-parametric testing
(Wilcoxon signed rank test) was used to evaluate the changes in
LV volumes, in global and regional myocardial mass, and in segmen-
tal strain values before and 6 months after ASA. All tests were two-
sided and the data were aggregated on the patient level. Linear
regression analysis was used to analyse the relationship between
percentage of remote mass reduction and improvement of the SI.
All statistical analyses were performed with SPSS version 11.0,
and signiﬁcance was set at a value of P  0.05.
Results
Mean age was 49+ 19 years (range 18–71, ﬁve males). Nine
patients received one or more drugs [beta-blocker (n ¼ 4),
calcium-channel blockers (n ¼ 7), or anti-arrhythmic drugs
(n ¼ 2)]. After ASA, the dose-regimen in patients using a
beta-blocker was continued; in two of the four patients
receiving both calcium-channel blockers and beta-blockers
pre-ablation, the calcium-channel blockers were discontin-
ued at follow-up. During the ablation procedure, ethanol
was injected in one septal artery in all patients. The mean
volume of ethanol injected during the ASA procedure was
4.1+ 1.4 mL (range 2.0–5.0 mL). The mean peak CK and
CK-MB release were 1881+ 831 U (range 991–3366) and
249+ 103 U (range 100–376), respectively. In ﬁve patients,
contrast-enhanced imaging was performed at baseline. In
four patients, small patchy areas of hyperenhanced myocar-
dium were observed in the ventricular wall and predomi-
nantly at the junctions of the RV and LV free walls. None
of the patchy areas were transmural, and no hyperenhance-
ment was observed in the antero- and postero-lateral
segments (remote area). The number of focal areas of
hyperenhancement per patient was 4.7+ 1.0, representing
an average mass of 0.5+ 0.5 g per area. Using DCE imaging
after the procedure, none of the patients had evidence of
infarct-related hyperenhancement outside the interventri-
cular septum. An example of the infarcted area as imaged
by DCE is shown in Figure 1.
The dynamic pressure gradient decreased from 91+ 15 to
11+ 15 mmHg at 6 months after the procedure (P, 0.001).
All patients reported subjective improvement of exercise
tolerance. The mean NYHA functional class improved signiﬁ-
cantly from 2.8+ 0.4 to 1.3+ 0.5 (P, 0.001) at 6 months
of follow-up.
Global ventricular function
Regional wall thickness, LV volumes, EF, and mass are sum-
marized in Table 1. The decrease in regional wall thickness
in the infarcted, adjacent, and remote myocardium was
signiﬁcant in all three regions. A signiﬁcant mass reduction
was observed both in the target septal myocardium and in
the non-septal myocardium (both P ¼ 0.008).
Regional myocardial function
Systolic strain
Figure 2 shows an example of ES short-axis-tagged images at
baseline and 6 months after the septal ablation procedure.
Figure 3 represents a 3D functional display of circumferen-
tial shortening (Ecc), computed from ﬁve short-axis- and
three long-axis-tagged views at baseline and at 6 months
of follow-up. Three-dimensional strain parameters are
listed in Table 2. Before ASA, myocardial function in the
target septal area was signiﬁcantly reduced when compared
with the remote myocardium (for SI, 29.7+ 4.2 vs.
216.9+ 2.8; P ¼ 0.008). After the artiﬁcially induced
septal infarction, no signiﬁcant changes of maximum systolic
strain were observed in the septum.
In the adjacent myocardium, radial stretch and longitudi-
nal shortening improved signiﬁcantly (P ¼ 0.02 and 0.01,
respectively), whereas circumferential shortening remained
unchanged. There was a trend in the improvement of the SI,
although it did not reach statistical signiﬁcance.
In the remote area, signiﬁcant improvement in myocardial
shortening was observed, reﬂected by the improved SI (from
216.9+ 2.8 to 218.8+ 3.2; P ¼ 0.017). Both circumferen-
tial shortening and longitudinal shortening improved signiﬁ-
cantly (P ¼ 0.049 and 0.041, respectively), whereas radial
stretch remained unchanged.
Systolic strain rates at baseline vs. follow-up
Before ASA, systolic strain rate in the septal target area was
signiﬁcantly lower when compared with that in the adjacent
and remote areas (both P ¼ 0.011) Figure 4. Six months
after the ablation procedure, systolic strain rates in the
infarct area did not change compared with baseline
Figure 1 DCE image in a short-axis view. Hyperenhancement in the
interventricular septum indicates the procedure-related infarct.
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(Table 3). However, in adjacent myocardium, all strain rates
except the circumferential shortening strain rate increased.
In remote myocardium, strain rates for all strain parameters
except for the circumferential–longitudinal shear strain
increased at follow-up (Table 3).
Correlation between remote mass reduction and SI
Linear regression analysis showed a strong positive correlation
(not statistically signiﬁcant) between per cent reduction of
non-septal mass and per cent improvement in SI in remote
myocardium at 6 months of follow-up (r ¼ 0.61, P ¼ 0.08).
Discussion
This is the ﬁrst study that used CMR tissue tagging and
3D-strain analysis to evaluate the effects on regional myo-
cardial function in symptomatic patients with HOCM after
ASA. As reported previously, both septal and non-septal
myocardial mass signiﬁcantly decreased as early as 1
month after septal ablation and progressed on mid-term
follow-up.10,11 This reduction in non-septal LV mass supports
the concept that myocardial hypertrophy in HOCM is partly
afterload-dependent and reversible. Using CMR tissue
tagging, we have now demonstrated that ASA improves
regional intramural myocardial systolic function in the
adjacent and remote myocardium. Both observations
support the concept that a reduction of LVOT obstruction
in symptomatic HOCM leads to reversed LV remodelling
after ASA. The observed positive correlation between the
percentage remote mass reduction and the improvement
of remote myocardial contraction supports the hypothesis
of a reversed remodelling process, although statistical sig-
niﬁcance could not be reached, which may be related to
the relatively small sample size of the study population.
Effect of ASA on myocardial mass
Although HCM is a genetic disorder leading to a primary
molecular abnormality resulting in an increase of wall thick-
ness, elimination of the LVOT obstruction will result in a
decrease of LV pressure and wall stress and subsequently
Table 1 Cardiac dimensions and mass at baseline and after ASA
Baseline 6 months follow-up D-value P-value
IVS thickness at infarct site (mm) 19.9+ 2.6 9.8+ 2.6 10.1+ 5.3 0.008
Wall thickness at mid LV level (mm)
Septal wall 17.3+ 5.5 15.3+ 5.8 2.0+ 1.8 0.02
Anterior wall 9.8+ 3.8 8.8+ 3.8 1.0+ 0.9 0.011
Lateral wall 7.3+ 1.1 6.3+ 1.0 1.0+ 0.9 0.011
Inferior wall 9.9+ 4.0 9.1+ 3.9 0.8+ 0.7 0.02
LV EDV (mL) 160+ 42 160+ 36 0.4+ 16 0.86
LV ESV (mL) 51+ 16 55+ 18 23.7+ 9 0.17
Stroke volume (mL) 109+ 26 104+ 21 4.8+ 14 0.34
LVEF (%) 68+ 3 66+ 5 2.2+ 5 0.33
Total LV mass (g) 203+ 59 168+ 50 34.9+ 16 0.008
Septal mass (g) 72+ 27 59+ 21 13.1+ 7 0.008
Non-septal mass (g) 131+ 34 109+ 30 21.8+ 11 0.008
Values expressed as mean+ SD. D, actual changes from baseline at 6-month follow-up.
Figure 2 ES short-axis-tagged CMR images in an HOCM patient at baseline (A) and at 6 months after ASA (B).
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in a regression of LV hypertrophy. Accordingly, previous
echocardiographic studies have demonstrated a signiﬁcant
reduction in LV mass at 1 year after septal ablation. This
was not only due to thinning of the septal myocardium,
but also due to a decrease in wall thickness throughout
the LV circumference.23 Using CMR, we demonstrated that
reversed LV remodelling after ASA was associated with
septal infarct location and correlated with reduction of
the LVOT pressure gradient.11 On the basis of these ﬁndings,
it was concluded that myocardial hypertrophy in HOCM is at
least in part afterload-dependent and reversible and not
exclusively caused by the genetic disorder.
Effect of ASA on regional myocardial function
In patients with hypertrophic cardiomyopathy, it has been
previously demonstrated that circumferential and
longitudinal shortening is decreased in the septal, anterior,
and inferior (hypertrophied) myocardial segments, compared
with normal subjects.24–26 Our 3D-strain data acquired prior
to the ablation procedure are in line with these observations.
Compared with baseline, systolic myocardial strains and
systolic strain rates in the target septal myocardium did
not change after ASA. Prior to intervention, septal systolic
deformation was already markedly reduced, and the for-
mation of scar tissue as a result of the ethanol-ablation
procedure did not lead to further impairment of the regional
septal function. In contrast, Abraham et al.13 found reduced
systolic function in the peri-infarct septal zone and
preserved systolic function in the non-ischaemic septal
zone after septal ablation, using strain rate imaging with
echocardiography. These ﬁndings are not contradictory to
the present results because, ﬁrst, in our study, the strain
analysis was calculated for the whole septum without
Table 2 Maximum systolic strains in septal, adjacent, and remote myocardium before and 6 months after ASA in HOCM
Maximum systolic strains Baseline Follow-up D-value P-value
Septum (antero- and inferoseptal wall)
Radial stretch (Err) 10.3+ 5.9 9.9+ 5.0 0.4+ 5.9 0.722
Circumferential shortening (Ecc) 210.8+ 3.6 211.0+ 3.0 0.2+ 1.3 0.672
Longitudinal shortening (Ell) 27.6+ 4.4 28.7+ 3.8 1.1+ 2.5 0.172
Torsion (Acl) (degrees) 7.4+ 3.1 7.0+ 3.4 0.4+ 1.6 0.594
SI 29.7+ 4.2 210.2+ 3.5 0.5+ 1.8 0.587
Adjacent (anterior and inferior wall)
Radial stretch (Err) 15.0+ 5.4 18.0+ 4.2 3.0+ 2.8 0.021
Circumferential shortening (Ecc) 215.6+ 5.5 216.4+ 4.1 0.8+ 2.9 0.528
Longitudinal shortening (Ell) 28.0+ 4.0 210.6+ 3.9 2.6+ 1.8 0.011
Torsion (Acl) (degrees) 8.2+ 2.8 8.4+ 2.1 0.2+ 1.9 0.767
SI 212.1+ 4.8 213.6+ 3.7 1.4+ 2.3 0.075
Remote (antero- and inferolateral wall)
Radial stretch (Err) 25.5+ 4.6 27.9+ 5.6 2.4+ 4.4 0.137
Circumferential shortening (Ecc) 222.1+ 3.6 223.5+ 3.3 1.5+ 2.0 0.050
Longitudinal shortening (Ell) 211.2+ 3.3 213.5+ 4.5 2.3+ 3.0 0.041
Torsion (Acl) (degrees) 8.3+ 2.1 8.8+ 1.3 0.5+ 2.5 0.859
SI 216.9+ 2.8 218.8+ 3.2 1.8+ 1.8 0.017
Values expressed as mean+ SD. D, actual changes from baseline at 6-month follow-up.
Figure 3 3D functional display of circumferential shortening (Ecc), calculated from ﬁve short-axis and three long-axis views at baseline (A) and at 6 months after
ASA (B).
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differentiation between infarcted and non-infarcted subre-
gions. Secondly, the difference in outcome is probably also
related to the fact that their patient group was studied
directly after the septal ablation procedure, at which time
myocardial stunning may have played a role. In contrast,
our CMR tagging data were acquired 6 months after ASA,
and the improvement in function of the non-ischaemic
septal myocardium may compensate for a loss of function
of the infarcted septal tissue.
SI, which incorporates both circumferential and longitudi-
nal shortening, has been introduced as a robust parameter
to quantify myocardial contraction.22 In the present study,
SI tended to increase in the adjacent myocardium and
improved signiﬁcantly in remote myocardium at 6 months
of follow-up, thereby demonstrating improved remote myo-
cardial contraction. Similar ﬁndings were reported after
afterload reduction as a result of valve replacement in
patients with aortic stenosis.27 In that study, normalization
of the LV torsion and a signiﬁcant increase in basal circum-
ferential shortening were observed 12 months after surgical
valve replacement. Furthermore, the increase in the cir-
cumferential shortening correlated with a decrease in the
LV mass index at 1-year follow-up. This also agrees with
our ﬁnding of a positive correlation between non-septal
mass reduction and the per cent increase of the SI of
remote myocardium at 6-month follow-up.
In a previous echocardiographic study, a decrease in the
Tei index was found, a Doppler parameter reﬂecting both
systolic and diastolic LV function, in the mid-term follow-up,
indirectly suggesting improvement of myocardial perform-
ance.12 Again, this is in agreement with the results of the
current study.
Limitations
Only a limited number of patients with HOCM were
studied, and the results should be interpreted with care.
Nevertheless, the 3D-strain data convincingly indicate that
signiﬁcant changes in regional myocardial function occur in
the non-infarcted (adjacent and remote) myocardial
regions after ASA. Furthermore, we have chosen to aggre-
gate the data on the patient level instead of using (for
instance) multilevel analysis. This was mainly done
because it improves the interpretability of the results.
In view of the limited number of patients, it must
be realized that CMR tissue tagging, especially when a
Figure 4 Typical example of regional SI strain curves in an HOCM patient pre- and post-ASA.
Table 3 Maximum systolic strain rate in septal, adjacent, and remote myocardium at baseline and 6 months after ASA in HOCM
Maximum systolic strain rate (strain/s) Baseline Follow-up D-value P-value
Antero- and inferoseptal wall
Radial stretch rate (Err) (strain/s) 46.7+ 22.4 48.6+ 17.7 2.0+ 23.1 0.953
Circumferential shortening rate (Ecc) (strain/s) 255.2+ 19.2 254.2+ 11.8 1.0+ 13.6 0.833
Longitudinal shortening rate (Ell) (strain/s) 235.2+ 17.3 241.2+ 19.0 6.0+ 11.6 0.159
Torsion rate (Acl) (degrees/s) 33.5+ 10.8 29.8+ 12.2 3.7+ 7.4 0.214
SI rate (strain/s) 246.8+ 19.2 249.5+ 14.4 2.7+ 8.4 0.399
Anterior and inferior wall
Radial stretch rate (Err/s) 62.8+ 20.2 81.5+ 10.8 18.7+ 16.2 0.021
Circumferential shortening rate (Ecc/s) 272.9+ 25.1 281.9+ 15.9 9.0+ 20.2 0.236
Longitudinal shortening rate (Ell/s) 237.5+ 17.5 250.5+ 17.5 13.0+ 6.9 0.007
Torsion rate (Acl/s) (degrees/s) 35.7+ 9.9 42.3+ 8.1 6.6+ 8.2 0.028
SI rate (SI/s) 256.5+ 21.1 270.0+ 16.7 13.5+ 11.9 0.017
Antero- and inferolateral wall
Radial stretch rate (Err/s) 90.5+ 17.0 111.1+ 30.3 20.6+ 26.2 0.049
Circumferential shortening rate (Ecc/s) 291.9+ 9.3 2102.3+ 10.8 10.4+ 11.8 0.034
Longitudinal shortening rate (Ell/s) 242.8+ 13.0 262.5+ 20.5 19.7+ 15.3 0.012
Torsion rate (Acl/s) (degrees/s) 34.8+ 10.0 41.7+ 6.2 6.9+ 11.7 0.11
SI rate (SI/s) 270.3+ 9.2 286.1+ 15.0 15.8+ 13.9 0.011
Values expressed as mean+ SD. D, actual changes from baseline at 6-month follow-up.
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four-dimensional (3-Dþ time) reconstruction of the LV is
made, is accompanied by a time-consuming post-processing
procedure. The number of tracked points within the LV wall
using CMR tissue (line) tagging with a tag–tag distance of
6–7 mm is limited, which, in turn, restricts the transmural
coverage of the strain calculations. More recently developed
strain imaging techniques, which allow for automated strain
analysis, may overcome these limitations in future studies.28
These methods, however, were not available to us at the
start of the study. Furthermore, we conﬁned our measure-
ments to systolic deformation, although HCM is also associ-
ated with impairment of diastolic function. Further work is
needed to study the changes in diastolic function after ASA.
In conclusion, we demonstrated that reduction in remote
myocardial mass after ASA was accompanied by a signiﬁcant
improvement of regional systolic myocardial function, sup-
porting a concept of structural and functional reversed LV
remodelling.
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